Workflow
惠每科技完成近2亿元新一轮融资,上海科创基金、钟鼎资本共同领投
Sou Hu Cai Jing·2025-08-18 06:36

Core Insights - HuiMei Technology, a leading company in medical AI solutions, has completed nearly 200 million yuan in a new financing round [1] - The financing was led by Shanghai Kechuang Fund and Zhongding Capital, with continued support from Qiming Venture Partners and Longning Capital [1] - Founded in 2015, HuiMei Technology focuses on applying AI technology to address clinical pain points by integrating real-time clinical data within hospitals [1] Company Overview - HuiMei Technology has developed three main solutions: AI-assisted clinical decision-making, real-time quality control, and cost control in clinical settings [1] - The company has established an AI clinical data foundation in over 1,200 hospitals over the past decade, enabling seamless integration of AI tools into doctors' workflows [1] Market Position - The company is recognized as a clear leader in China's clinical AI medical market, with a continuously growing market share [1] - The recent approval of the "Artificial Intelligence +" action plan by the State Council is expected to further enhance the development of AI in healthcare [1] Future Prospects - HuiMei Technology aims to leverage its research and development advantages and international positioning in Shanghai to promote its AI best practices globally [1] - The company is positioned to deepen the integration of AI technology in clinical applications, enhancing its role as an "AI assistant" for healthcare professionals [1]